{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:47:56Z","timestamp":1773287276749,"version":"3.50.1"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/crd.0b013e318199e9b7","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T16:19:34Z","timestamp":1242922774000},"page":"115-120","source":"Crossref","is-referenced-by-count":61,"title":["Therapeutic Angiogenesis in the Management of Critical Limb Ischemia"],"prefix":"10.1097","volume":"17","author":[{"given":"Steve","family":"Attanasio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Snell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210203","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","article-title":"ACC\/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"issue":"suppl 1","key":"R2-3-20210203","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II).","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"R3-3-20210203","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0741-5214(92)90417-7","article-title":"Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease.","volume":"16","author":"Albers","year":"1992","journal-title":"J Vasc Surg"},{"key":"R4-3-20210203","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-130-5-199903020-00005","article-title":"Prostanoids for chronic critical limb ischemia. A randomized, controlled, open-label trial with prostaglandin E1. Ischemia Cronica degli Arti Inferiori.","volume":"130","year":"1999","journal-title":"Ann Intern Med"},{"key":"R5-3-20210203","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0140-6736(98)05069-7","article-title":"Spinal-cord stimulation in critical limb ischemia: a randomized trial.","volume":"353","author":"Klomp","year":"1999","journal-title":"Lancet"},{"key":"R6-3-20210203","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/1534734605283538","article-title":"Current state and perspective on medical treatment of critical leg ischemia: gene and cell therapy.","volume":"4","author":"Emmerich","year":"2005","journal-title":"Low Extrem Wounds"},{"key":"R7-3-20210203","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/00029330-200806010-00001","article-title":"Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia.","volume":"121","author":"Gu","year":"2008","journal-title":"Chin Med J"},{"key":"R8-3-20210203","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease.","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat Med"},{"key":"R9-3-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yjmcc.2003.10.002","article-title":"Simons M. Re-evaluating therapeutic neovascularization.","volume":"36","author":"de Munick","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"R10-3-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/mic.10.1.83.97","article-title":"The development and growth of collateral arteries.","volume":"10","author":"Helisch","year":"2003","journal-title":"Microcirculation"},{"key":"R11-3-20210203","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0140-6736(96)03361-2","article-title":"Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischemic limb.","volume":"348","author":"Isner","year":"1996","journal-title":"Lancet"},{"key":"R12-3-20210203","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0008-6363(03)00258-X","article-title":"De novo vasculogenesis in the heart.","volume":"58","author":"Luttun","year":"2008","journal-title":"Cardiovasc Res"},{"key":"R13-3-20210203","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/01.CIR.97.12.1114","article-title":"Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.","volume":"97","author":"Baumgartner","year":"1998","journal-title":"Circulation"},{"key":"R14-3-20210203","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1067\/mva.2002.123677","article-title":"Naked plasmid DNA encoding fibroblast growth factor type I for the treatment of end-stage reconstructible lower extremity ischemia: preliminary results of the phase I trial.","volume":"35","author":"Comerota","year":"2002","journal-title":"J Vasc Surg"},{"key":"R15-3-20210203","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/mthe.2002.0638","article-title":"Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study.","volume":"6","author":"M\u00e4kinen","year":"2002","journal-title":"Mol Ther"},{"key":"R16-3-20210203","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/hc3201.095192","article-title":"Adenovirus-mediated gene transfer of VEGF (121) improves lower-extremity endothelial function and flow reserve.","volume":"104","author":"Rajagopalan","year":"2001","journal-title":"Circulation"},{"key":"R17-3-20210203","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.0000093398.16124.29","article-title":"Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.","volume":"108","author":"Rajagopalan","year":"2003","journal-title":"Circulation"},{"key":"R18-3-20210203","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9343(02)01392-X","article-title":"Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia.","volume":"114","author":"Shyu","year":"2003","journal-title":"Am J Med"},{"key":"R19-3-20210203","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/01.CIR.97.4.381","article-title":"Potentiated angiogenic effect of scatter factor\/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.","volume":"97","author":"Van Belle","year":"1998","journal-title":"Circulation"},{"key":"R20-3-20210203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/71527","article-title":"PR39, a peptide regulator of angiogenesis.","volume":"6","author":"Li","year":"2000","journal-title":"Nat Med"},{"key":"R21-3-20210203","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1050-1738(02)00186-X","article-title":"Harnessing the response to tissue hypoxia: HIF-1 alpha and therapeutic angiogenesis.","volume":"12","author":"Vincent","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"R22-3-20210203","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.106.607994","article-title":"Use of a constitutively active hypoxia-inducible factor-1 transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience.","volume":"115","author":"Rajagopalan","year":"2007","journal-title":"Circulation"},{"key":"R23-3-20210203","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.vph.2006.03.009","article-title":"Gene therapy of the ischemic lower limb- therapeutic angiogenesis.","volume":"44","author":"Bobek","year":"2006","journal-title":"Vasc Pharmacol"},{"key":"R24-3-20210203","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1253\/circj.71.1181","article-title":"A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel\u2013an Initial Report of the Phase I-IIa Study.","volume":"71","author":"Marui","year":"2007","journal-title":"Circ J"},{"key":"R25-3-20210203","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo.","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"R26-3-20210203","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.mehy.2004.07.039","article-title":"The use of transformed Escherichia coli for experimental angiogenesis induced by regulated in situ production of vascular endothelial growth factor-an alternative gene therapy.","volume":"64","author":"Celec","year":"2005","journal-title":"Med Hypotheses"},{"key":"R27-3-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1479-5876-6-45","article-title":"Allogeneic endometrial regenerative cells: an \u201coff the shelf solution\u201d for critical limb ischemia?","volume":"6","author":"Murphy","year":"2008","journal-title":"J Transl Med"},{"key":"R28-3-20210203","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(02)08937-7","article-title":"Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomized controlled trial.","volume":"359","author":"Lederman","year":"2002","journal-title":"Lancet"},{"key":"R29-3-20210203","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ahj.2007.01.038","article-title":"Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.","volume":"153","author":"Grossman","year":"2007","journal-title":"Am Heart J"},{"key":"R30-3-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1191\/1358863x03vm460oa","article-title":"Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial.","volume":"8","author":"Mohler","year":"2003","journal-title":"Vasc Med"},{"key":"R31-3-20210203","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/hum.2006.17.683","article-title":"Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.","volume":"17","author":"Kusumanto","year":"2006","journal-title":"Hum Gene Ther"},{"key":"R32-3-20210203","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/mt.2008.33","article-title":"Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia.","volume":"16","author":"Nikol","year":"2008","journal-title":"Mol Ther"},{"key":"R33-3-20210203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCULATIONAHA.107.727347","article-title":"Results of a double-blind, placebo-controlled study, to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.","volume":"118","author":"Powell","year":"2008","journal-title":"Circulation"},{"key":"R34-3-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.108.784371","article-title":"Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age.","volume":"118","author":"Tongers","year":"2008","journal-title":"Circulation"},{"key":"R35-3-20210203","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.ATV.20.12.2573","article-title":"Co-administration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization.","volume":"20","author":"Chae","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R36-3-20210203","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.282.5388.468","article-title":"Increased vascularization in mice overexpressing angiopoietin-1.","volume":"282","author":"Suri","year":"1998","journal-title":"Science"},{"key":"R37-3-20210203","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1096\/fj.02-0377fje","article-title":"Fibroblast growth factor 4 induces vascular permeability, angiogenesis, and arteriogenesis in a rabbit hindlimb ischemia model.","volume":"17","author":"Rissanen","year":"2003","journal-title":"FASEB J"},{"key":"R38-3-20210203","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/sj.gt.3302481","article-title":"Angiogenesis is confined to the period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.","volume":"12","author":"Gounis","year":"2005","journal-title":"Gene Ther"},{"key":"R39-3-20210203","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/sj.gt.3301339","article-title":"Microbubble-enhanced ultrasound for vascular gene delivery.","volume":"7","author":"Lawrie","year":"2000","journal-title":"Gene Ther"},{"key":"R40-3-20210203","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jss.2005.01.005","article-title":"Vascular endothelial growth factor gene delivery by magnetic DNA nanospheres ameliorates limb ischemia in rabbits.","volume":"126","author":"Jiang","year":"2005","journal-title":"J Surg Res"},{"key":"R41-3-20210203","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/SLA.0b013e318153fdcb","article-title":"Progenitor cell therapy in patients with critical limb ischemia without surgical options.","volume":"247","author":"Sprengers","year":"2008","journal-title":"Ann Surg"},{"key":"R42-3-20210203","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis.","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"R43-3-20210203","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1161\/hc2301.092122","article-title":"Mobilization of endothelial progenitor cells in patients with acute myocardial infarction.","volume":"103","author":"Shintani","year":"2001","journal-title":"Circulation"},{"key":"R44-3-20210203","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/hc3501.093817","article-title":"Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines.","volume":"104","author":"Kamihata","year":"2001","journal-title":"Circulation"},{"key":"R45-3-20210203","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial.","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet"},{"key":"R46-3-20210203","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1253\/circj.71.196","article-title":"Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia.","volume":"71","author":"Kajiguchi","year":"2007","journal-title":"Circ J"},{"key":"R47-3-20210203","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1253\/circj.68.1189","article-title":"Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells.","volume":"68","author":"Saigawa","year":"2004","journal-title":"Circ J"},{"key":"R48-3-20210203","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/modpathol.2008.48","article-title":"Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia.","volume":"21","author":"Van Huyen","year":"2008","journal-title":"Modern Pathol"},{"key":"R49-3-20210203","first-page":"51","article-title":"Intramuscular or combined intramuscular\/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.","volume":"49","author":"Van Tongeren","year":"2008","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"R50-3-20210203","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/diacare.28.9.2155","article-title":"Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.","volume":"28","author":"Huang","year":"2005","journal-title":"Diabetes Care"},{"key":"R51-3-20210203","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1160\/TH07-02-0137","article-title":"Randomized comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.","volume":"98","author":"Huang","year":"2007","journal-title":"Thromb Hemost"},{"key":"R52-3-20210203","first-page":"1017","article-title":"A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia [in Chinese].","volume":"20","author":"Gu","year":"2006","journal-title":"Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi"},{"key":"R53-3-20210203","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1253\/circj.70.1093","article-title":"Granulocyte colony-stimulating factor- a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease.","volume":"70","author":"Arai","year":"2006","journal-title":"Circ J"},{"key":"R54-3-20210203","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.104.529552","article-title":"START trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease.","volume":"112","author":"van Royen","year":"2005","journal-title":"Circulation"},{"key":"R55-3-20210203","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1161\/01.CIR.94.12.3291","article-title":"Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer.","volume":"94","author":"Asahara","year":"1996","journal-title":"Circulation"},{"key":"R56-3-20210203","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0140-6736(99)09405-2","article-title":"Ex-vivo gene therapy of human bypass grafts with E2F decoy: the PREVENT single-centre, randomized, controlled trial.","author":"Mann","year":"1999","journal-title":"Lancet"},{"key":"R57-3-20210203","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","article-title":"Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.","volume":"43","author":"Conte","year":"2006","journal-title":"J Vasc Surg"},{"key":"R58-3-20210203","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1253\/circj.72.1385","article-title":"Angiogenesis achieved by granulocyte colony-stimulating factor in combination with bypass surgery in 2 cases of critical limb ischemia.","volume":"72","author":"Nakayama","year":"2008","journal-title":"Circ J"},{"key":"R59-3-20210203","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nature06613","article-title":"HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1.","volume":"451","author":"Arany","year":"2008","journal-title":"Nature"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045415-200906000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:56:33Z","timestamp":1618034193000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-200906000-00003"}},"subtitle":["Current Concepts and Review"],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0b013e318199e9b7","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}